Artigo Acesso aberto Revisado por pares

Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes

2010; Lippincott Williams & Wilkins; Volume: 5; Issue: 4 Linguagem: Inglês

10.2215/cjn.07891109

ISSN

1555-905X

Autores

Laura Plantinga, Deidra C. Crews, Josef Coresh, Edgar R. Miller, Rajiv Saran, Jerry Yee, Elizabeth Hedgeman, Meda E. Pavkov, Mark S. Eberhardt, Desmond E. Williams, Neil R. Powe,

Tópico(s)

Diabetes, Cardiovascular Risks, and Lipoproteins

Resumo

Prevalence of chronic kidney disease (CKD) in people with diagnosed diabetes is known to be high, but little is known about the prevalence of CKD in those with undiagnosed diabetes or prediabetes. We aimed to estimate and compare the community prevalence of CKD among people with diagnosed diabetes, undiagnosed diabetes, prediabetes, or no diabetes.The 1999 through 2006 National Health and Nutrition Examination Survey is a representative survey of the civilian, noninstitutionalized US population. Participants who were aged > or =20 years; responded to the diabetes questionnaire; and had fasting plasma glucose (FPG), serum creatinine, and urinary albumin-creatinine ratio measurements were included (N = 8188). Diabetes status was defined as follows: Diagnosed diabetes, self-reported provider diagnosis (n = 826); undiagnosed diabetes, FPG > or =126 mg/dl without self-reported diagnosis (n = 299); prediabetes, FPG > or =100 and <126 mg/dl (n = 2272); and no diabetes, FPG or =30 mg/g; adjustment was performed with multivariable logistic regression.Fully 39.6% of people with diagnosed and 41.7% with undiagnosed diabetes had CKD; 17.7% with prediabetes and 10.6% without diabetes had CKD. Age-, gender-, and race/ethnicity-adjusted prevalence of CKD was 32.9, 24.2, 17.1, and 11.8%, for diagnosed, undiagnosed, pre-, and no diabetes, respectively. Among those with CKD, 39.1% had undiagnosed or prediabetes.CKD prevalence is high among people with undiagnosed diabetes and prediabetes. These individuals might benefit from interventions aimed at preventing development and/or progression of both CKD and diabetes.

Referência(s)